Charles Schwab
SBRA icon

Charles Schwab’s Sabra Healthcare REIT SBRA Stock Holding History

Charles Schwab’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.4M Buy
4,840,401
+67,098
+1% +$1.33M 0.01% 822
2026
Q1 		$91.8M Buy
4,773,303
+49,757
+1% +$980K 0.01% 775
2025
Q4 		$89.5M Buy
4,723,546
+334,737
+8% +$6.2M 0.01% 787
2025
Q3 		$81.8M Sell
4,388,809
-58,558
-1% -$1.09M 0.01% 828
2025
Q2 		$82M Sell
4,447,367
-263,913
-6% -$4.68M 0.01% 773
2025
Q1 		$82.3M Buy
4,711,280
+6,317
+0.1% +$107K 0.02% 753
2024
Q4 		$81.5M Buy
4,704,963
+3,082
+0.1% +$56.3K 0.02% 782
2024
Q3 		$87.5M Buy
4,701,881
+365,855
+8% +$6.17M 0.02% 745
2024
Q2 		$66.8M Buy
4,336,026
+87,514
+2% +$1.25M 0.01% 853
2024
Q1 		$62.8M Buy
4,248,512
+57,925
+1% +$802K 0.01% 860
2023
Q4 		$59.8M Buy
4,190,587
+94,304
+2% +$1.34M 0.02% 852
2023
Q3 		$57.1M Buy
4,096,283
+116,444
+3% +$1.49M 0.02% 795
2023
Q2 		$46.8M Buy
3,979,839
+18,926
+0.5% +$215K 0.01% 892
2023
Q1 		$45.6M Buy
3,960,913
+56,583
+1% +$700K 0.01% 907
2022
Q4 		$48.5M Buy
3,904,330
+89,808
+2% +$1.15M 0.02% 837
2022
Q3 		$50M Buy
3,814,522
+29,954
+0.8% +$443K 0.02% 755
2022
Q2 		$52.9M Buy
3,784,568
+163,373
+5% +$2.18M 0.02% 717
2022
Q1 		$53.9M Buy
3,621,195
+193,550
+6% +$2.65M 0.02% 825
2021
Q4 		$46.4M Buy
3,427,645
+285,064
+9% +$4.03M 0.01% 948
2021
Q3 		$46.3M Buy
3,142,581
+205,496
+7% +$3.47M 0.02% 931
2021
Q2 		$53.5M Buy
2,937,085
+63,741
+2% +$1.13M 0.02% 814
2021
Q1 		$49.9M Buy
2,873,344
+8,895
+0.3% +$156K 0.02% 829
2020
Q4 		$49.8M Buy
2,864,449
+46,470
+2% +$742K 0.02% 769
2020
Q3 		$38.8M Sell
2,817,979
-24,002
-0.8% -$353K 0.02% 793
2020
Q2 		$41M Buy
2,841,981
+527,377
+23% +$6.93M 0.02% 706
2020
Q1 		$25.3M Buy
2,314,604
+428,199
+23% +$7.9M 0.01% 851
2019
Q4 		$40.3M Buy
1,886,405
+478,800
+34% +$10.7M 0.02% 751
2019
Q3 		$32.3M Buy
1,407,605
+112,387
+9% +$2.4M 0.02% 854
2019
Q2 		$25.5M Buy
1,295,218
+15,022
+1% +$293K 0.02% 977
2019
Q1 		$24.9M Buy
1,280,196
+19,809
+2% +$375K 0.02% 969
2018
Q4 		$20.8M Buy
1,260,387
+24,308
+2% +$489K 0.02% 976
2018
Q3 		$28.6M Buy
1,236,079
+21,567
+2% +$489K 0.02% 899
2018
Q2 		$26.4M Buy
1,214,512
+64,647
+6% +$1.26M 0.02% 886
2018
Q1 		$20.3M Buy
1,149,865
+72,029
+7% +$1.27M 0.02% 992
2017
Q4 		$20.2M Sell
1,077,836
-62,298
-5% -$1.24M 0.02% 969
2017
Q3 		$25M Buy
1,140,134
+580,906
+104% +$13.1M 0.02% 757
2017
Q2 		$13.5M Buy
559,228
+57,014
+11% +$1.45M 0.01% 1127
2017
Q1 		$14M Sell
502,214
-57,813
-10% -$1.52M 0.01% 1068
2016
Q4 		$13.7M Buy
560,027
+25,343
+5% +$581K 0.02% 1026
2016
Q3 		$13.5M Buy
534,684
+199,870
+60% +$4.79M 0.02% 947
2016
Q2 		$6.91M Buy
334,814
+26,038
+8% +$543K 0.01% 1330
2016
Q1 		$6.2M Buy
308,776
+10,886
+4% +$209K 0.01% 1377
2015
Q4 		$6.03M Buy
297,890
+31,004
+12% +$653K 0.01% 1386
2015
Q3 		$6.19M Buy
266,886
+23,024
+9% +$587K 0.01% 1331
2015
Q2 		$6.28M Buy
243,862
+16,100
+7% +$457K 0.01% 1399
2015
Q1 		$7.55M Sell
227,762
-4,324
-2% -$140K 0.01% 1204
2014
Q4 		$7.05M Buy
232,086
+61,803
+36% +$1.7M 0.01% 1164
2014
Q3 		$4.14M Buy
170,283
+12,582
+8% +$349K 0.01% 1532
2014
Q2 		$4.53M Buy
157,701
+21,921
+16% +$637K 0.01% 1483
2014
Q1 		$3.79M Buy
135,780
+16,200
+14% +$445K 0.01% 1549
2013
Q4 		$3.13M Buy
119,580
+15,887
+15% +$410K 0.01% 1624
2013
Q3 		$2.46M Buy
103,693
+10,071
+11% +$248K 0.01% 1722
2013
Q2 		$2.47M Buy
+93,622
New +$2.7M 0.01% 1625

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
LIMS
Lasalle Investment Management Securities Baltimore, Maryland $2.81B AUM 16.57% 1-Year Est. Return

Charles Schwab's SBRA Position: Q2 2026 in Review

Charles Schwab increased its Sabra Healthcare REIT (SBRA) stake by 1.4% in Q2 2026, buying an estimated $1.33M and bringing the position to 4,840,401 shares worth $94.4M. The position accounts for 0.01% of the portfolio, ranked #822.

Charles Schwab first reported a position in SBRA in Q2 2013 and has held it in 53 quarters since. 462 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Charles Schwab held 4,840,401 shares of Sabra Healthcare REIT worth $94.4M as of Q2 2026.
  • Charles Schwab bought 67,098 Sabra Healthcare REIT shares in Q2 2026, an estimated $1.33M.
  • Sabra Healthcare REIT made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #822 holding.
  • Charles Schwab first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 53 quarters since.
  • 462 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.